5[1]Amoroso A, Del-Porto F, Di MC, et al. Vascular endothelial growth factor: a key mediator of neoangiogenesis[J]. Eur Rev Med Pharmacol Sci, 1997, 1(1-3): 17-25.
6[4]Harris AL. Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy[J]. Recent Results Cancer Res, 1998,152:341-352.
7[5]Ferrara N , Davis-Smyth T. The biology of vascular enclothelial growth factor[J]. Endccr Rev, 1997, 18(1): 4-25.
8[6]Iruela-Arispe ML, Dvorak HF. Angiogenesis: a dynamic balance of stimulators and inhibitors[J]. Thromb Haemost, 1997, 78(1): 672-677.
9[8]Park J, Keller GA, Fearara N. The vascular endothelial growth factor (VEGF) isoforms: differenctial deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF[J].Mol Biol Cell, 1993, 4(12): 1317-1326.
10[9]Brown LF, Detmar M, Claffey K, et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine[J]. EXS, 1997,79:233-269.
